276 related articles for article (PubMed ID: 17342796)
1. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy.
Hoque SR; Black MM; Cliff S
Clin Exp Dermatol; 2007 Mar; 32(2):172-5. PubMed ID: 17342796
[TBL] [Abstract][Full Text] [Related]
2. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature.
Barnadas M; Roe E; Brunet S; Garcia P; Bergua P; Pimentel L; Puig L; Francia A; García R; Gelpí C; Sierra J; Coll P; Alomar A
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):69-74. PubMed ID: 16405612
[TBL] [Abstract][Full Text] [Related]
3. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
Rossum MM; Verhaegen NT; Jonkman MF; Mackenzie MA; Koster A; Van Der Valk PG; Span LF
Leuk Lymphoma; 2004 Nov; 45(11):2327-32. PubMed ID: 15512825
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
[TBL] [Abstract][Full Text] [Related]
5. Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus.
Schadlow MB; Anhalt GJ; Sinha AA
J Drugs Dermatol; 2003 Oct; 2(5):564-7. PubMed ID: 14558407
[TBL] [Abstract][Full Text] [Related]
6. [A case of follicular lymphoma complicated with lethal pemphigus].
Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus.
Borradori L; Lombardi T; Samson J; Girardet C; Saurat JH; Hügli A
Arch Dermatol; 2001 Mar; 137(3):269-72. PubMed ID: 11255323
[No Abstract] [Full Text] [Related]
8. Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.
Aoi J; Makino K; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Koga H; Hashimoto T; Ihn H
J Dermatol; 2013 Apr; 40(4):285-6. PubMed ID: 23398274
[No Abstract] [Full Text] [Related]
9. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K
Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608
[TBL] [Abstract][Full Text] [Related]
10. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
Allen KJ; Wolverton SE
J Drugs Dermatol; 2007 Sep; 6(9):883-9. PubMed ID: 17941359
[TBL] [Abstract][Full Text] [Related]
12. A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma.
Moustafa MA; Seningen JL; Jouni H; Singh PP; el-Azhary RA; Witzig TE
Am J Hematol; 2013 Sep; 88(9):822-3. PubMed ID: 23658142
[No Abstract] [Full Text] [Related]
13. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Plumb R; Doolittle GC
Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab.
Ito Y; Makita S; Maeshima AM; Hatta S; Suzuki T; Yuda S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Intern Med; 2018 Aug; 57(16):2395-2398. PubMed ID: 29526963
[TBL] [Abstract][Full Text] [Related]
16. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
Taintor AR; Leiferman KM; Hashimoto T; Ishii N; Zone JJ; Hull CM
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
[TBL] [Abstract][Full Text] [Related]
17. Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy.
Hwang YY; Chan JC; Trendell-Smith NJ; Kwong YL
Intern Med J; 2014 Nov; 44(11):1145-6. PubMed ID: 25367731
[No Abstract] [Full Text] [Related]
18. Paraneoplastic pemphigus in a burn intensive care unit: case report and review of the literature.
Hayanga AJ; Lee TM; Pannucci CJ; Knipp BS; Olsen SH; Wang SC; Napolitano LM
J Burn Care Res; 2010; 31(5):826-9. PubMed ID: 20683196
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.
Kikuchi T; Mori T; Shimizu T; Koda Y; Abe R; Kurihara Y; Funakoshi T; Yamagami J; Sato H; Tsunoda K; Amagai M; Okamoto S
Ann Hematol; 2017 Jul; 96(7):1221-1222. PubMed ID: 28447163
[No Abstract] [Full Text] [Related]
20. Paraneoplastic pemphigus associated with systemic mastocytosis.
Eccersley LR; Hoffbrand AV; Rustin MH; McNamara CJ
Am J Hematol; 2009 Dec; 84(12):847-8. PubMed ID: 19544477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
